Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Non-Oral Extravascular Drug Absorption Routes01:15

Non-Oral Extravascular Drug Absorption Routes

Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more effectively...
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
Methods for Studying Drug Absorption: In situ01:09

Methods for Studying Drug Absorption: In situ

In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Good practice for aerosol therapy by nebulization in 2020].

Revue des maladies respiratoires·2020
Same author

[Inhalation therapy: provocation tests, infectious risks, acute bronchiolitis and ENT diseases. GAT aerosolstorming, Paris 2011].

Revue des maladies respiratoires·2012
Same author

[Use of pentamidine nebulization in children].

Revue des maladies respiratoires·2012
Same author

[Inhalation devices: characteristics, modeling, regulation and use in routine practice. GAT Aerosolstorming, Paris 2011].

Revue des maladies respiratoires·2012
Same author

[Bronchiolitis obliterans postallogeneic stem cell transplantation: what is new?].

Revue de pneumologie clinique·2011
Same author

Inhaled insulin: a model for pulmonary systemic absorption?

Revue des maladies respiratoires·2010

Related Experiment Video

Updated: Jul 5, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

[Inhaled insulin: a model for pulmonary systemic absorption?].

M-H Becquemin1, J-P Chaumuzeau

  • 1Faculté de Médecine et Université Denis Diderot, Paris VII, Groupe Hospitalier Pitié-Salpétrière et UPRES 2397, Paris, France. marie-helene.becquemin@psl.aphp.fr

Revue Des Maladies Respiratoires
|May 2, 2008
PubMed
Summary
This summary is machine-generated.

Inhaled insulin offers a new alternative to injections, potentially improving insulin therapy initiation. While absorption is faster, bioavailability is lower, but increased in smokers, with long-term safety still under investigation.

More Related Videos

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion
07:30

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion

Published on: December 13, 2024

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Related Experiment Videos

Last Updated: Jul 5, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion
07:30

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion

Published on: December 13, 2024

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Area of Science:

  • Pharmacology
  • Pulmonology
  • Endocrinology

Context:

  • The European Union has approved an inhaled insulin formulation, presenting a novel alternative to traditional injectable insulin.
  • Insulin therapy initiation is often delayed due to patient apprehension regarding injections.

Purpose:

  • To review the challenges and considerations associated with the pulmonary route for systemic insulin absorption.
  • To compare the pharmacokinetics and bioavailability of inhaled versus injectable insulin.
  • To assess the potential obstacles and long-term safety of inhaled insulin therapy.

Summary:

  • Inhaled insulin demonstrates comparable pharmacokinetics to injectable forms, with faster absorption but lower overall bioavailability.
  • Bioavailability of inhaled insulin is notably increased in smokers.
  • Potential side effects like cough and increased anti-insulin antibodies, along with cost, are considered manageable, but long-term safety, especially in specific populations, requires further study.

Impact:

  • Facilitates insulin therapy initiation by offering a non-injectable alternative.
  • Highlights the need for clear indications and further research into the long-term safety of inhaled insulin, particularly concerning its mitogenic potential.